LCM
VRCA icon

Laurion Capital Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Laurion Capital Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,000
Closed -$325K – 1445
2018
Q3 		$325K Hold
2,000
– – ﹤0.01% 920
2018
Q2 		$395K Buy
+2,000
New +$392K ﹤0.01% 1018

Other funds holding VRCA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CI
Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return

Laurion Capital Management's VRCA Position: Q4 2018 in Review

Laurion Capital Management sold out of Verrica Pharmaceuticals (VRCA) in Q4 2018, closing a stake of 2,000 shares — an estimated $325K sold.

Laurion Capital Management first reported a position in VRCA in Q2 2018 and held it in 2 quarters. The position peaked at $395K in Q2 2018. 40 funds tracked by Wall St. Rank hold VRCA as of Q4 2018.

  • Laurion Capital Management reported no remaining Verrica Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Laurion Capital Management sold 2,000 Verrica Pharmaceuticals shares in Q4 2018, an estimated $325K.
  • Laurion Capital Management first reported a position in Verrica Pharmaceuticals in Q2 2018 and held it in 2 quarters.
  • Laurion Capital Management's Verrica Pharmaceuticals position peaked at $395K in Q2 2018.
  • 40 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2018.

Based on Laurion Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.